Despite the availability of large funds and considerable efforts to improve access to antiretroviral therapy (ART), coverage of treatment with ART remains low in Democratic Republic of the Congo (DRC). We identified the bottlenecks for adults' access to ART in a semi-rural health zone in DRC, compared ART coverage in the urban and rural area and described the outcomes and yield of different HIV testing settings. An operational model was used to examine bottlenecks in the flow of patients. The study period covered the start of the HIV care programme in April 2006, until December 2008. An estimated 505 People Living With HIV/AIDS (PLWHA), of whom 201 were in need of ART, lived in the health zone. The proportion of PLWHA in need of ART who were actually receiving ART was estimated at 53%. About 6451 adults were tested for HIV, 266 of them were HIVpositive and 163 accessed the HIV care programme. About 106 of the 126Á159 eligible patients initiated ART. The main bottleneck was situated at HIV detection. Access to the HIV care programme for the patients testing HIV-positive was identified as the second biggest bottleneck. About 41% of the PLWHA identified in urban areas accessed the HIV care programme, versus 11% of the rural PLWHA, showing a serious inequity. The tuberculosis (TB) programme detected 75% of the total estimated 92 co-infected patients of the health zone. Only 13% of women testing positive in the Prevention of Mother-To-Child Transmission programme accessed the HIV care programme, showing that this bottleneck is greatly accentuated in this specific group. By testing all pregnant women and all TB patients in the health zone, 28% of all PLWHA could potentially be detected in a period of 33 months, showing its great potential in settings with a relatively low HIV prevalence.
Introduction
Since its independence in 1960, the Democratic Republic of the Congo (DRC) has faced economic decline (Demographic Health Survey, Democratic Republic of the Congo, 2007) , resulting in a low per capita Gross National Product, limited reach of government services, and breakdown of communication systems and infrastructure. In the 2010 index of failed states (Failed States Index, 2010) , DRC is ranked the fifth worst country in the world. DRC is facing enormous challenges to provide health care, including HIV care. Gaps left by the government are filled by numerous non-governmental and faith-based organisations.
HIV prevalence in DRC has recently been estimated at 1.3% (Demographic Health Survey, Democratic Republic of the Congo, 2007) . The Demographic and Health Survey estimates the prevalence in people living in urban and rural areas at 1.9 and 0.7%, respectively.
Despite the availability of large funds and considerable efforts to improve access to antiretroviral therapy (ART) (Rapport national de situation a`l'intention de l'UNGASS, Re´publique de´mocratique du Congo, janvierÁjuillet 2007), coverage of treatment with ART in DRC is low. The WHO ''3 by 5'' target for DRC was 80,000 people receiving ART. The Global Fund's Performance Monitoring Report mentions only 13,064 people who were receiving ART on the 30th June 2007 (Global Fund Performance Monitoring Report DRC, 6th November 2007) . With coverage of less than 10%, DRC is classified amongst the worst countries in the world in terms of scaling-up (Report on the global AIDS Epidemic, Joint United Nations Programme on HIV/ AIDS, 2006) . According to national data, only 4.1% of all adults have been tested for HIV in a year's time (Rapport national de situation a`l'intention de l'UNGASS, Re´publique de´mocratique du Congo, janvierÁjuillet 2007), which suggests that lack of HIV testing is an important bottleneck. About 70% of HIV-positive patients who started ART are still in therapy 12 months after the initiation. A major obstacle for appropriate ART *Corresponding author. Email: saracongo@hotmail.com Care Vol. 23, No. 6, June 2011, 686Á693 delivery programmes is patient loss to follow-up. High rates (35%) of loss to follow-up !6 months since the last clinic visit have been reported in DRC. Cumulative incidence of death among lost patients is high (Atibu Losoma, Kiumbu, Azinyue, Mukumbi, & Ryder, 2009) . No data are available on the total number of the detected HIV-positive people who registered at an HIV care programme, neither about the proportion of eligible patients amongst patients registered and the proportion of eligible patients who initiated ART, in DRC.
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The aim of this research is to identify the bottlenecks of access to ART in a health zone in DRC, using an operational model. The study compares the proportion actually on ART with the estimated number in need of ART. It identifies the problems that arise at different steps of an operational flow model (Dujardin, Kegels, Buve´, & Mercenier, 1997) , by evaluating the proportion of HIV-positive people who know their HIV status, the proportion of those who access the HIV care programme, the proportion of eligible patients at clinic level and the proportion initiating ART. The study compares access for patients living in the urban and rural areas of the health zone. It compares HIV prevalence, and access to the HIV care programme for patients tested in different testing settings. It evaluates the yield of the different HIV testing sites and estimates their potential to detect an important number of people living with HIV.
Methods

Setting
Kisantu is a semi-rural health zone in Bas-Congo province with a surface of 240 square kilometres and an estimated total population of 144,395 inhabitants, 73,205 of whom live in the urban area of Kisantu town and 71,190 in rural villages. The main economic activity is subsistence farming (70% of the active population) while 20% of the population make a living with small-scale commercial and other informal activities, and 10% is employed by the government.
Based on data from the Demographic Health Survey, HIV prevalence in Kisantu is roughly estimated at 1% for the urban population and 0.4% for the rural population. The HIV care programme is integrated and centralised in the mission hospital Saint Luc, located in Kisantu town, and managed by the Ministry of Health. No health care providers outside this programme are providing ART.
The programme receives rapid antibody tests, antiretroviral medicines and drugs for opportunistic infections treatment funded by the Global Fund to Fight AIDS, Tuberculosis (TB) and Malaria.
HIV testing is performed in the hospital, in two rural and three urban maternity wards, in the TB diagnostic and treatment centre located in the hospital, and in one urban community-based Voluntary testing and Counselling (VCT) centre. The HIV testing site in the hospital receives referrals by clinicians as well as clients who wish to know their HIV status on a voluntary basis. All pregnant women presenting at the antenatal clinics in the five maternities where a Prevention of Mother-To-Child Transmission (PMTCT) programme is implemented, are advised to be tested for HIV, using an opt-out strategy. Kisantu has four TB centres for diagnosis and treatment. Three of them are rural and the fourth is located in the hospital. HIV testing is only available for TB patients treated in the hospital site, according to an opt-out strategy.
CD4 counts are only freely available for TB/HIV co-infected patients. For the other patients, eligibility is based on clinical staging and total lymphocyte count, according to the national guidelines. All patients, whether eligible for ART or not, are asked to visit the HIV clinic every month.
Framework for estimation of patients' flow
The flow model used in this study is based upon an operational model for the analysis of TB control programmes, developed by Piot (1967) , who at that time was attached to WHO. In this study our simplified model has four steps ( Figure 1 ).
To estimate the number of people in need for treatment, the software package Spectrum (Stover Step 1
Step 2
Step 3 Step 4 Proportion: , about 50% of the population of DRC is estimated to be older than 15 years. We used the regional prevalence of 0.7%, observed in Western DRC (Demographic Health Survey, Democratic Republic of the Congo, 2007).
Proportions of patients in different HIV testing sites
In order to estimate the yield of different types of testing sites like the TB programme and the PMTCT programme, we used the following formula: ART eligibility status was checked using the national criteria for initiation of antiretroviral treatment (Ministry of Health, 2008) .
The number and residence of patients starting ART were extracted in an anonymous way from the ART register of the HIV care programme.
All PLWHA with residence outside of Kisantu health zone were excluded from the analysis of the patients' flow, but were included in the evaluation of the performance of different testing sites and the yield of TB and PMTCT programmes.
According to data from the WHO TB report (Global tuberculosis control Á epidemiology, strategy, financing. WHO report 2009), the national incidence rate of TB is estimated at 392/100,000 pop/year and the HIV prevalence in incident TB cases at 5.9%.
The estimation of the number of pregnant women in Kisantu is based on data published in the Demographic Health Survey. In Bas-Congo province, the prevalence of pregnancy is 9.6% among women between 15 and 49 years. For a population of 144,395 inhabitants, 3032 women are estimated to be pregnant at any one time.
According to official reports from Kisantu health zone, the HIV prevalence of pregnant women in the PMTCT programme is 0.6%.
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Results
Proportions of People Living With HIV/AIDS (PLWHA) in the operational flow
During the study period an estimated 505 adults in Kisantu health zone were living with HIV, of whom 266 (53%) were identified in the HIV testing sites and 239 HIV infected adults remained unaware of their condition. About 62 people who were identified with HIV during the study period were living outside of Kisantu health zone. Of the 266 PLWHA of Kisantu health zone that were identified, 163 (61%) accessed the hospital's HIV care programme during the study period. Ten PLWHA who accessed the HIV care programme were living outside Kisantu health zone. About 126 of those living in Kisantu health zone who accessed the HIV care programme were identified as eligible and four as non-eligible for ART. For 33 patients who were not initiated on ART, eligibility status remained unknown, as their personal files could not be found in the hospital. The exact number of eligible patients is thus between 126 and 159 patients.
About 106 eligible patients living in Kisantu health zone initiated ART. Between 20 and 53 eligible patients got lost at this step (Table 1) .
Overall 32% (53% )61%) of the estimated number of adult PLWHA in the health zone accessed the HIV care programme. According to the outcomes of the analysis with the Spectrum software package, 201 patients were estimated to be in need of ART in Kisantu during the study period. With 106 patients who were initiated on ART, ART coverage of 53% was reached.
In the urban area of Kisantu, 41% of the estimated PLWHA accessed the HIV care programme and 65% of the estimated 145 patients in need initiated ART. In the rural area, 11% of all PLWHA accessed the HIV care programme and 21% of the estimated 56 patients in need initiated ART.
Proportions of patients in different HIV testing sites
About 6451 adults have been tested for HIV in the health zone during the study period. About 328 of them tested HIV-positive, resulting in an average AIDS Care 689 prevalence of 5% for all testing settings together ( Table 2) . The estimated number of TB patients in the health zone is 566 per year, so 1557 for the whole study period. About 92 patients amongst them are estimated to be infected with HIV, of whom the TB programme detected 75%.
The estimated yearly number of pregnant women in the health zone is 3032, which means 8338 pregnant women for the whole study period. About 50 pregnant women were estimated to be infected with HIV, meaning that the PMTCT programme detected 48% of the estimated number of HIVpositive pregnant women in the health zone.
The TB and PMTCT programme together could theoretically detect 142 patients, which is 28% of the estimated 505 PLWHA living in the health zone, as illustrated in Table 3 .
Discussion
Limitations of the study
There are several aspects of the study design that call for some caution in the interpretation of the results. Firstly, the data used in this study highly depend on the estimation of the prevalence of HIV, TB and fertility rates of the general population. Secondly, this is a small-scale study with rather small proportions of patients, especially at the later steps of the model. Extrapolation of these data might not be accurately representative of a large-scale HIV programme. A large-scale study containing data of different health zones, or a country national level, would be interesting in this respect.
Although the study evaluates how many patients reach the steps of the operational flow within the study period, it does not reveal how much time patients take to proceed to the next step. For example, an HIV-positive person, who is ignorant of his status today, may want to go for testing in a few years' time, when he will become aware of his HIV-related symptoms. The exact outcomes of the drop-offs remain unknown and therefore it cannot be determined in which group of drop-offs the highest mortality occurs, neither which proportion in each group of drop-offs will proceed eventually to the next step. In fact, any definition of loss to follow-up at any step of the flow model can be seen as arbitrary as a patient who is late can never be considered as definitively lost unless he is reported to be dead. However, even if the proportion of dead patients among patients lost to follow-up is unknown, loss to programme can undoubtedly be seen as a programme failure indicator.
Furthermore, CD4 counts are not systematically quantified in each patient, which does not allow a This study provides only quantitative data, but to gain more insight in the determinants behind the awareness and health-seeking behaviour of the population, identified as two important bottlenecks, qualitative studies are needed. Aspects that have not been covered in this study are the quality of counselling and HIV care, children's access to ART, psychosocial follow-up, adherence to ART and prevention. Other studies are needed to cover these aspects.
Proportions of People Living With HIV/AIDS (PLWHA) in the operational flow
The estimated ART coverage is much higher in Kisantu (53%) than nationally (less than 10%) because in the majority of health zones of DRC the HIV care programme is not implemented, due to insufficient funding.
Poor coverage of HIV testing has been explained in other resource-limited contexts by poor healthseeking behaviour, stigma in society and operational challenges. Apart from two health centres with a PMTCT programme, all testing sites are located in the urban area. Transportation problems are probably the main obstacle for people living in rural areas. In a successful programme of scaling-up VCT in Kenya (Marum, Taegtmeyer, & Chebet, 2006) , similar findings have been documented: ''The national target number of testing sites has been exceeded, although the target number of sites for each district has not been achieved in the districts in remote or hard-to-reach areas, and a programme to increase mobile VCT tries to compensate for this poor access''. In DRC, decentralisation of VCT to the health centres and health posts might be a good solution, but many personnel will have to be trained. Furthermore, it will be difficult to overcome the inequity in access to the HIV care programme, if over time its provision will still remain in one central site. According to WHO, many countries suffer from urban concentration of health professionals and rural deficits (World Health Organisation, 2006) . Strategies to decentralise HIV care should be developed, as in Lusikisiki, in rural South Africa, where a greater proximity and acceptability of services at the clinic level led to faster enrolment of people receiving treatment (Bedelu, Ford, Hilderbrand, & Reuter, 2007) .
The second biggest bottleneck, being access to the HIV care programme for those who have been identified with HIV, could be regarded as more crucial because the HIV care programme is not capable of treating all patients that are detected. The explanation is probably multifactoral. It may be due to a poor referral system between the testing sites and the HIV care programme or related to the healthseeking behaviour of people tested HIV-positive. A high proportion of PLWHA who accessed the HIV care programme are eligible, which means that people are detected and/or registered when they may be aware of their illness. The fact that ART coverage in all eligible patients in the health zone is better than the PLWHA coverage of the HIV care programme, suggests that the HIV care programme selected the more severe ''eligible'' cases.
Outcomes of different HIV testing services
The good flow of the TB/HIV co-infected patients to the HIV care programme and the high loss to followup of HIV-infected pregnant women, are probably explained by the patients' awareness of their health status. This study shows that TB control programmes have a great potential of identifying persons infected by HIV in settings with low HIV prevalence: with only a low percentage of TB patients who have been tested for HIV, a high proportion of HIV patients of the health zone are picked up by the programme, because health care worker-initiated settings of hospitalised patients and persons suspected of having TB are ideal settings in which to identify large numbers of persons with advanced HIV infection (Marum et al., 2006) . The high uptake of HIV testing in the maternity departments and the TB programme is most likely linked to their opt-out strategy. Looking at the proportions that accessed the HIV care programme, the identified bottleneck also seems to be linked to operational aspects of HIV testing site. The community-based VCT site (with 75% access of HIV-positive patients to the HIV care programme) routinely performed active follow-up of those tested positive.
With the observed HIV prevalence of 0.6% in pregnant women, the PMTCT programme could theoretically detect 10% of all PLWHA, by testing 11.6% of the total adult population. However, the prevalence we observed might be underestimated as in Bas-Congo province, 2% of women in PMTCT programmes were tested HIV-positive (Rapport d'ac-tivite´s 2007 du PNLS, Democratic Republic of the Congo). On the other hand, according to a survey of UNAIDS in sub-Saharan Africa (UNAIDS, 2007) , the HIV prevalence of women attending antenatal clinics is 1.25 times higher than the prevalence obtained by a demographic health survey, which would for Bas-Congo would mean 0.87% of pregnant women.
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The opt-out strategy in the PMTCT programme has only a small impact on the health status of the HIV-positive mothers in Kisantu, because a limited proportion of them obtain HIV care, as has been shown in other studies as well (Kumar, Kilaru, Kumari, Ford, & Waterman, 2008; Manzi et al., 2005) . Improving the referral system between PMTCT programmes and the HIV care programme is a priority. In the TB clinic, patients had regular appointments to collect the TB drug, and a detailed register allowed tracking of each co-infected patient. DOTS has been used now for many years to provide successful anti-TB treatment to millions of patients in poor countries of the world, and the ART programme may benefit from many of the established concepts of a TB programme (Libamba et al., 2005) . Based on the better performance of TB programmes in detection, referral and care of people found to have HIV infection, other programmes like those of STI control and reproductive health care would benefit from a more standardised approach with an opt-out strategy of HIV testing and a more rigorous referral and treatment protocol.
We also suppose that TB patients who suspect they are co-infected with HIV may be more likely to seek care at the TB clinic of the referral hospital, the only TB treatment centre that performs HIV testing. Alternatively, the prevalence of HIV in TB patients may be substantially higher in Kisantu (15%) than the national numbers presented by WHO (5.9%), which would increase the actual yield of the TB programme.
In conclusion, the model we used allowed us to identify two important bottlenecks of access to ART, and helps to decide on which approach to adopt to improve access. The probability that a patient does proceed from one step to the next is a measure of the performance of different disease control activities. Poor coverage of HIV testing has been detected in other studies, but more research is required to discover the exact underlying causes for the high loss to follow-up of people with a positive HIV test result. Further investigation could identify weaknesses in the referral system of the programme, patients' possible denial of the test result, adherence to an alternative care circuit or death. Drop-offs at different levels have not only been observed in ART programmes, but also in studies of control of sexually transmitted diseases (Buve´et al., 2001) and TB (Dujardin et al., 1997) .
Given the low rate of loss to follow-up at all steps of patients with TB/HIV co-infection, who benefit from a rigorous approach, we think that the way forward for other disease control programmes is to integrate HIV care in a standardised way. Improving the referral system between PMTCT programmes and the HIV care programme is a priority. This study takes into account all activities related to the HIV care programme, and gives therefore a realistic overview of the strengths and weaknesses at each level. Loss to follow-up at any step of the programme is a crucial indicator of failure of programme performance in tracking the outcomes of care.
